Neural Network-Based Histologic Remission Prediction In Ulcerative Colitis
Authors:
Yemin li,
Zhongcheng Liu,
Xiaoying Lou,
Mirigual Kurban,
Miao Li,
Jie Yang,
Kaiwei Che,
Jiankun Wang,
Max Q. -H Meng,
Yan Huang,
Qin Guo,
Pinjin Hu
Abstract:
BACKGROUND & AIMS: Histological remission (HR) is advocated and considered as a new therapeutic target in ulcerative colitis (UC). Diagnosis of histologic remission currently relies on biopsy; during this process, patients are at risk for bleeding, infection, and post-biopsy fibrosis. In addition, histologic response scoring is complex and time-consuming, and there is heterogeneity among pathologi…
▽ More
BACKGROUND & AIMS: Histological remission (HR) is advocated and considered as a new therapeutic target in ulcerative colitis (UC). Diagnosis of histologic remission currently relies on biopsy; during this process, patients are at risk for bleeding, infection, and post-biopsy fibrosis. In addition, histologic response scoring is complex and time-consuming, and there is heterogeneity among pathologists. Endocytoscopy (EC) is a novel ultra-high magnification endoscopic technique that can provide excellent in vivo assessment of glands. Based on the EC technique, we propose a neural network model that can assess histological disease activity in UC using EC images to address the above issues. The experiment results demonstrate that the proposed method can assist patients in precise treatment and prognostic assessment.
METHODS: We construct a neural network model for UC evaluation. A total of 5105 images of 154 intestinal segments from 87 patients undergoing EC treatment at a center in China between March 2022 and March 2023 are scored according to the Geboes score. Subsequently, 103 intestinal segments are used as the training set, 16 intestinal segments are used as the validation set for neural network training, and the remaining 35 intestinal segments are used as the test set to measure the model performance together with the validation set.
RESULTS: By treating HR as a negative category and histologic activity as a positive category, the proposed neural network model can achieve an accuracy of 0.9, a specificity of 0.95, a sensitivity of 0.75, and an area under the curve (AUC) of 0.81.
CONCLUSION: We develop a specific neural network model that can distinguish histologic remission/activity in EC images of UC, which helps to accelerate clinical histological diagnosis.
keywords: ulcerative colitis; Endocytoscopy; Geboes score; neural network.
△ Less
Submitted 28 August, 2023;
originally announced August 2023.
Extending the Neural Additive Model for Survival Analysis with EHR Data
Authors:
Matthew Peroni,
Marharyta Kurban,
Sun Young Yang,
Young Sun Kim,
Hae Yeon Kang,
Ji Hyun Song
Abstract:
With increasing interest in applying machine learning to develop healthcare solutions, there is a desire to create interpretable deep learning models for survival analysis. In this paper, we extend the Neural Additive Model (NAM) by incorporating pairwise feature interaction networks and equip these models with loss functions that fit both proportional and non-proportional extensions of the Cox mo…
▽ More
With increasing interest in applying machine learning to develop healthcare solutions, there is a desire to create interpretable deep learning models for survival analysis. In this paper, we extend the Neural Additive Model (NAM) by incorporating pairwise feature interaction networks and equip these models with loss functions that fit both proportional and non-proportional extensions of the Cox model. We show that within this extended framework, we can construct non-proportional hazard models, which we call TimeNAM, that significantly improve performance over the standard NAM model architecture on benchmark survival datasets. We apply these model architectures to data from the Electronic Health Record (EHR) database of Seoul National University Hospital Gangnam Center (SNUHGC) to build an interpretable neural network survival model for gastric cancer prediction. We demonstrate that on both benchmark survival analysis datasets, as well as on our gastric cancer dataset, our model architectures yield performance that matches, or surpasses, the current state-of-the-art black-box methods.
△ Less
Submitted 17 November, 2022; v1 submitted 14 November, 2022;
originally announced November 2022.
